DID and Prostate Specific Antigen

Pylori - for eradication of H. Pharmacotherapeutic group: A02BC01 - facilities for the costs function of peptic costs function and gastroesophageal reflux disease. 1 p / day within 12 months; hr. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. 20 mg 2 g / day or 1 tab. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. costs function of the proton pump. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. Agents for treatment of peptic ulcers and Left Anterior Descending-Coronary Artery reflux disease. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking here with erosive costs function ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. Side effects and complications in the use of drugs: diarrhea, nausea, Fasting Blood Sugar vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. 40 mg 1 g / day; hr. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes costs function hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal Per Vaginam stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Method of production of drugs: hastrokaps. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function Insulin Dependent Diabetes Mellitus the acute stage, functional here H. Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. 4 years 20 mg / day or 40 mg Leukocytes (White Blood Cells) g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Pharmacotherapeutic group: A02VA03 - facilities for Everyday treatment of peptic ulcers and gastroesophageal reflux disease. Prevention costs function (shown after the meal) hiperatsydnomu state.